Year: 2026

At 2025 consumption levels, the NdPr oxide Sarfartoq is expected to produce annually from ST1 alone would represent approximately 34% of all NdPr oxide refined outside China

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — INNOVATE CORP.® (NYSE: VATE) (“INNOVATE” or the “Company”) announced today the successful closing of the previously announced transaction between INNOVATE and CONX Corp. (“CONX”), pursuant to which CONX acquired a controlling interest in HC2 Broadcasting Holdings Inc. (“HC2”), a holding company for INNOVATE’s Broadcasting segment. The transaction follows the completion of the Broadcasting segment’s refinancing announced on June 1, 2026.

The acquisition adds AI-powered due diligence and monitoring to Nasdaq eVestment™ and deepens the platform’s coverage of private markets.

The acquisition adds AI-powered due diligence and monitoring to Nasdaq eVestment™ and deepens the platform's coverage of private markets.

MediWound to Present at the H.C. Wainwright 28^th Annual Global Investment Conference

Company plans to advance the interim analysis of its Phase III Namodenoson study in advanced hepatocellular carcinoma

Oxford, UK and Boston, MA – 2 September 2026 – Sitryx Therapeutics (“the Company”), a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune and inflammatory disease, today announced that management will be participating in the following upcoming investor conferences:

Descent will remain an independent subsidiary as Charles IT invests in AI-driven automation and the next generation of managed IT services

Descent will remain an independent subsidiary as Charles IT invests in AI-driven automation and the next generation of managed IT services

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets

Bastion’s team and strategies join CoinShares as the Company’s Active Alternative Strategies business

FORM 8.3

FORM 8.3

Jyske Bank A/S (Jyske Bank) has entered into a binding agreement with the shareholders of FP Kapital A/S on the acquisition of 100% of the shares of FP Kapital A/S (Formuepleje).

Jyske Bank A/S (Jyske Bank) har indgået en bindende aftale med aktionærerne i FP Kapital A/S om erhvervelse af 100% af aktierne i FP Kapital A/S (Formuepleje).

NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) — Quantumsphere Acquisition Corporation (Nasdaq: QUMS) (the “Company”) announced today that the Company, QUMS Pubco Ltd. and SACH Merge Sub Ltd. (collectively, the “Purchaser Parties”) have terminated the Agreement and Plan of Merger, dated October 3, 2025 (the “Merger Agreement”), with Omnivate Global Ltd. and SACH Pte. Ltd. (“SACH”).

GREENVILLE, S.C., Sept. 01, 2026 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”) today announced the completion of the previously announced sale of its equipment finance business, consisting of Navitas Credit Corp. and NLFC Reinsurance Corp. (collectively, “Navitas”), to funds managed by Wafra Inc., acting through Navitas TopCo LLC (“Wafra”) for approximately $2.0 billion in cash¹ (the “Transaction”).

California Resources Corporation Completes Acquisition of Crimson